Giant cell arteritis in Lugo, Spain: A more frequent disease with fewer classic features

Journal of Rheumatology

Volumn 24, Issue 11, 1997, Pages 2166-2170

  González Gay, Miguel A ^a,b   Blanco, Ricardo ^a,b   Sánchez Andrade, Amalia ^a,b   Vázquez Caruncho, Manuel ^a,c  

^a HOSPITAL XERAL CALDE   (Spain)

^b Rheumatology Division

^c Radiology Division   (Italy)

Author keywords

Giant cell (temporal) arteritis; Spain; Temporal artery biopsy incidence

Indexed keywords

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ARTICLE; FEMALE; GIANT CELL ARTERITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SPAIN; TEMPORAL ARTERY; THROMBOCYTOSIS;

AGED; AGED, 80 AND OVER; BIOPSY; BLINDNESS; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA; RETROSPECTIVE STUDIES; SPAIN; TEMPORAL ARTERIES; TEMPORAL ARTERITIS;

EID: 1842369049     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Healy LA, Wilske KR: Manifestations of giant cell arteritis. Med Clin North Am 1977;61:261-70.
2. Hunder GG, Ward LE, Burbank MK: Giant-cell arteritis producing an aortic arch syndrome. Ann Intern Med 1967;66:578-82.
3. Lie JT and Members and Consultants of the American College of Rheumatology Subcommittee on Classification of Vasculitis: Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 1990;33:1074-87.
4. Machado EBV, Michet CJ, Ballard DJ, et al: Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum 1988;31:745-9.
5. Nordborg E, Bengtsson BA: Epidemiology of biopsy-proven giant cell arteritis. J Intern Med 1990;227:233-6.
6. Salvarani C, Macchioni P, Zizzi F, et al: Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in Northern Italy. Arthritis Rheum 1991;34:351-6.
7. Baldursson O, Steinsson K, Bjornsson J, Lie JT: Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum 1994;37:1007-12.
8. Barrier J, Pion P, Massari R, Peltier P, Rojouan J, Grolleau JY: Approche épidémiologique de la maladie de Horton dans le départment de Loire-Atlantique: 110 cas en 10 ans (1970-1979). [Epidemiologic approach to Horton's disease in the region of Loire-Atlantique: 110 cases in 10 years (1970-1979).] Rev Med Interne 1983;3:13-20.
9. Friedman G, Friedman B, Benbassat J: Epidemiology of temporal arteritis in Israel. Isr J Med Sci 1982;18:241-4.
10. Smith CA, Fidler WJ, Pinals RS: The epidemiology of giant cell arteritis: Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum 1983;26:1214-9.
11. González-Gay MA, Alonso MD, Agüero JJ, Bal M, Fernández-Camblor B, Sánchez-Andrade A: Temporal arteritis in a Northwestern area of Spain: Study of 57 biopsy proven patients. J Rheumatol 1992;19:277-80.
12. Hunder GG, Lie JT, Goronzy JJ, Weyand CM: Pathogenesis of giant cell arteritis. Arthritis Rheum 1993;36:757-61.
13. Calamia KT, Moore SB, Elvebach LR, Hunder GG: HLA-DR locus antigens in polymyalgia rheumatica and giant cell arteritis. J Rheumatol 1981;8:993-6.
14. Richardson JE, Gladman DD, Fam A, Keystone EC: HLA-DR4 in giant cell arteritis: Association with polymyalgia rheumatica syndrome. Arthritis Rheum 1987;30:1293-7.
15. Sonnenblick M, Nesher G, Friedlander Y, Rubinow A: Giant cell arteritis in Jerusalem: A 12-year epidemiological study. Br J Rheumatol 1994;33:938-41.
16. González-Gay MA, Alonso MD, Agüero JJ, Bal M, Fernández-Camblor B, Sánchez-Andrade A: Giant cell arteritis in Mediterranean countries (letter). Salvarani C, Machioni P, Boiardi L, Lodi L, Portioli I: (reply). Arthritis Rheum 1992;35:1249-50.
17. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT: Polymyalgia rheumatica. A 10 year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
18. Cohen MD, Ginsburg WW: Polymyalgia rheumatica. Rheum Dis Clin North Am 1990;16:325-39.
19. Armitage P, Berry G: Further analysis of categorical data. In: Armitage P, Berry G, eds. Statistical Methods in Medical Science. Oxford: Blackwell, 1994:436-43.
20. Braitman LE: Confidence intervals assess both clinical significance and statistical significance. Ann Intern Med 1991;114:515-6.
21. Spiera H, Davison S: Treatment of polymyalgia rheumatica. Arthritis Rheum 1982;25:120-4.
22. Sonnenblick M, Nesher G, Kramer MR, Gottschalk S: Increased frequency of temporal arteritis. Harefuah 1986;110:556-8.
23. Fainaru M, Friedman G, Friedman B: Temporal arteritis in Israel. A review of 47 patients. J Rheumatol 1979;6:330-5.
24. Weyand CM, Hunder NNH, Hicok KC, Hunder GG, Goronzy GG: HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 1994;37:514-20.
25. Elling P, Olsson AT, Elling H: Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol 1996;23:112-9.
26. Salvarani C, Gabriel SE, O'Fallon WM: The incidence of giant cell arteritis in Olmsted County, Minnesota: Apparent fluctuations in a cyclic pattern. Ann Intern Med 1995;123:192-4.